Profil
Boris Oklander is the founder of C2i Genomics, Inc. which is founded in 2019, where he currently holds the title of Chief Technology Officer.
He also worked as the Chief Algorithm Developer at GBooking Ltd.
Dr. Oklander received his undergraduate, graduate, and doctorate degrees from Technion-Israel Institute of Technology.
Postes actifs de Boris Oklander
| Sociétés | Poste | Début |
|---|---|---|
C2i Genomics, Inc.
 C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Fondateur | 01/01/2019 |
Anciens postes connus de Boris Oklander
| Sociétés | Poste | Fin |
|---|---|---|
GBooking Ltd.
 GBooking Ltd. Packaged SoftwareTechnology Services GBooking Ltd. develops and provides online appointment scheduling software solutions. It provides small and medium-sized businesses with web-based online promotion and advertising tools. The company was founded by Alexander Naslednikov, Liran Gavish, Alexander Bryzgalov, Ronen Kagan and Fadi Karkaby in 2010 and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - |
Formation de Boris Oklander
| Technion-Israel Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
GBooking Ltd.
GBooking Ltd. Packaged SoftwareTechnology Services GBooking Ltd. develops and provides online appointment scheduling software solutions. It provides small and medium-sized businesses with web-based online promotion and advertising tools. The company was founded by Alexander Naslednikov, Liran Gavish, Alexander Bryzgalov, Ronen Kagan and Fadi Karkaby in 2010 and is headquartered in Haifa, Israel. | Technology Services |
C2i Genomics, Inc.
C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Technology Services |
